A specialty
vaccine company
TOTAL
revenues 2020
Our employees
Valneva’s success stems from the dedication and expertise of approximately 580 employees spanning the whole value chain, from R&D to commercialization.
2020 Highlights
In 2020, Valneva achieved several major milestones, further enhancing its unique value proposition.
Our strategy
Valneva aims to build a leading vaccines company with a portfolio of specialized assets targeting diseases with limited preventive or therapeutic treatment options.
Frédéric Jacotot General Counsel and Corporate Secretary
Our Corporate Governance Approach
Our commitment to Corporate Governance underpins the trust that our investors, employees and institutions have placed in us.
Corporate Social Responsibility
Valneva has defined long-term responsible business commitments, which reflect global health needs and sit across four key focus areas. Our four pillars are the foundation for our Corporate Social Responsibility approach.